Seaport Therapeutics, Inc. Common Stock

NASDAQ:SPTX

Biotechnology

Healthcare
$18.31 +0.58%

+$0.10 today

Market cap
$980.14M
Beta
0.00
52W Low $14.85High $23.00

Volume 0.68M

Average 0.41M

SPTX Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

No reported Accounts Receivables figures are available to summarize.

Accounts Receivables history

Currency unavailable · from the cash flow

No Accounts Receivables data reported for this period type.

Accounts Receivables vs competitors

How SPTX compares with its peers on the latest reported figures

SPTX Competitors
Accounts Receivables for SPTX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
VNDAVanda Pharmaceuticals Inc.LTM Mar 2026$12.33M USD+56.3%+89.9%5.7%
LBRXLB Pharmaceuticals Inc Common StockLTM Mar 2026$205K USD———
RAPPRapport Therapeutics, Inc. Common StockLTM Mar 2026$58K USD——0.3%
GHRSGH Research PLCLTM Mar 2026$0 USD———
CTNMContineum Therapeutics, Inc. Class A Common StockLTM Mar 2026$0 USD———
MPLTMapLight Therapeutics, Inc.LTM Mar 2026$0 USD———
NMRANeumora Therapeutics, Inc. Common StockLTM Mar 2026$0 USD———
SPTXSeaport Therapeutics, Inc. Common Stock—— ———
Peer median (excluding SPTX) —+56.3%+89.9%3.0%

Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Seaport Therapeutics, Inc. Common Stock

NASDAQ:SPTX

Intrinsic Alpha fair value

Locked

Current Price

$18.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.